113 related articles for article (PubMed ID: 9027768)
1. Calcium channel blockers: what they can and what they can't do.
Menè P
Nephrol Dial Transplant; 1997 Jan; 12(1):25-8. PubMed ID: 9027768
[No Abstract] [Full Text] [Related]
2. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
3. Modification of the renal effects of ouabain by calcium channel blockers.
Cruz-Soto MA; Martínez-Maldonado M
Adv Exp Med Biol; 1984; 178():319-27. PubMed ID: 6391100
[No Abstract] [Full Text] [Related]
4. Renal effects of calcium entry blockers.
Ruilope LM; Alcazar JM
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():979-82. PubMed ID: 2076410
[TBL] [Abstract][Full Text] [Related]
5. Vascular effects of calcium channel antagonists: new evidence.
Richard S
Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
[TBL] [Abstract][Full Text] [Related]
6. [Interaction of 1,4-dihydropyridines with ion channels].
Veizerová L; Svetlík J; Kettmann V
Ceska Slov Farm; 2008 Apr; 57(2):58-62. PubMed ID: 18578414
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockers: current controversies and basic mechanisms of action.
Clusin WT; Anderson ME
Adv Pharmacol; 1999; 46():253-96. PubMed ID: 10332505
[No Abstract] [Full Text] [Related]
8. Do calcium channel blockers protect against renal ischemia?
Puschett JB
Am J Nephrol; 1987; 7 Suppl 1():49-56. PubMed ID: 3327381
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Mortell KH; Anderson DJ; Lynch JJ; Nelson SL; Sarris K; McDonald H; Sabet R; Baker S; Honore P; Lee CH; Jarvis MF; Gopalakrishnan M
Bioorg Med Chem Lett; 2006 Mar; 16(5):1138-41. PubMed ID: 16380257
[TBL] [Abstract][Full Text] [Related]
10. [The pharmacology of calcium channel blockers].
Knorr A
Pharm Unserer Zeit; 2005; 34(5):380-7. PubMed ID: 16180360
[No Abstract] [Full Text] [Related]
11. Combination antihypertensive therapy in the treatment of diabetic nephropathy.
Boner G; Cao Z; Cooper ME
Diabetes Technol Ther; 2002; 4(3):313-21. PubMed ID: 12165170
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition.
Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
Transplantation; 1992 Dec; 54(6):1103-6. PubMed ID: 1465778
[No Abstract] [Full Text] [Related]
13. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II.
Takenaka T; Suzuki H; Okada H; Inoue T; Kanno Y; Ozawa Y; Hayashi K; Saruta T
Kidney Int; 2002 Aug; 62(2):558-65. PubMed ID: 12110018
[TBL] [Abstract][Full Text] [Related]
14. [The comparative characteristics of the renal protective properties of angiotensin-converting enzyme inhibitors and calcium channel blockers].
Kolesnyk MO; Lapchyns'ka II; Hromova AIe; Kassyr KhI
Lik Sprava; 2000; (3-4):11-5. PubMed ID: 10921249
[No Abstract] [Full Text] [Related]
15. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
Hansen PB
Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
[TBL] [Abstract][Full Text] [Related]
16. Renal consequences of antihypertensive therapy.
Eknoyan G; Suki WN
Semin Nephrol; 1991 Mar; 11(2):129-37. PubMed ID: 1674622
[No Abstract] [Full Text] [Related]
17. Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins.
Olivera BM; Miljanich GP; Ramachandran J; Adams ME
Annu Rev Biochem; 1994; 63():823-67. PubMed ID: 7979255
[No Abstract] [Full Text] [Related]
18. Calcium channels and calcium channel blockers.
Seth SD; Seth S
Indian J Physiol Pharmacol; 1991 Oct; 35(4):217-31. PubMed ID: 1667398
[No Abstract] [Full Text] [Related]
19. Functional role of sodium-calcium exchange in the regulation of renal vascular resistance.
Schweda F; Seebauer H; Krämer BK; Kurtz A
Am J Physiol Renal Physiol; 2001 Jan; 280(1):F155-61. PubMed ID: 11133525
[TBL] [Abstract][Full Text] [Related]
20. Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin.
Fallet RW; Ikenaga H; Bast JP; Carmines PK
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F545-51. PubMed ID: 15536171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
